Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of treatment prior to death among those with lung cancer: A national study in a universal healthcare context.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

Numbness on the Medical Take: An Atypical Presentation of Guillain-Barre Syndrome With Unilateral Paraesthesia and Rapid Progression to Bulbar Palsy: A Case Report.

Clinical case reports·2024
Same author

Health status and heat preparation at a UCI World Tour multistage cycling race.

Journal of science and medicine in sport·2024
Same author

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024
Same author

Reduction in re-rupture rates following implementation of return-to-sport testing after anterior cruciate ligament reconstruction in 313 patients with a mean follow-up of 50 months.

Journal of ISAKOS : joint disorders & orthopaedic sports medicine·2024
Same author

Phosphine estimation in fumigated food grains using gas chromatography equipped with FPD detector.

Environmental monitoring and assessment·2023

Related Experiment Video

Updated: Jul 8, 2026

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Admissions screening: clinical benefits.

C C Korvin, R H Pearce, J Stanley

    Annals of Internal Medicine
    |August 1, 1975
    PubMed
    Summary

    Routine laboratory screening in hospitals yields many abnormal results, but few lead to significant patient benefit. Careful evaluation is needed to determine the clinical value of these diagnostic findings.

    Area of Science:

    • Clinical chemistry
    • Hematology
    • Diagnostic testing

    Background:

    • Routine laboratory testing is common in hospitalized patients.
    • Assessing the clinical utility of numerous abnormal test results is crucial for efficient healthcare.

    Purpose of the Study:

    • To evaluate the clinical benefit of routine chemical and hematologic tests in hospitalized patients.
    • To determine the diagnostic yield and impact of abnormal laboratory findings.

    Main Methods:

    • Prospective analysis of 20 chemical and hematologic tests for 1000 patients admitted to a general hospital.
    • Assessment of potential clinical benefit for all abnormal results identified.

    Main Results:

    • 2223 abnormal results were found in 1000 patients.

    More Related Videos

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
    10:38

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

    Published on: January 16, 2019

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    Related Experiment Videos

    Last Updated: Jul 8, 2026

    High Content Screening in Neurodegenerative Diseases
    13:32

    High Content Screening in Neurodegenerative Diseases

    Published on: January 6, 2012

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
    10:38

    Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

    Published on: January 16, 2019

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

  • Only 83 new diagnoses were made in 77 patients, with no unequivocally beneficial outcomes.
  • Up to 30 patients may have benefited from diligent follow-up; 39 had insignificant findings.
  • Conclusions:

    • Despite a high number of abnormal screening tests, the clinical benefits are not impressive.
    • The diagnostic yield of routine laboratory screening requires critical evaluation to justify its use.
    • Further research into optimizing laboratory test selection and follow-up protocols is warranted.